Dataset from A Phase 1, Randomized, Double-Blinded, Placebo-Controlled, Single- and Multiple-Ascending Dose, Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of BIIB095 in Healthy Subjects
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00007217
下载链接
链接失效反馈官方服务：
资源简介：
The primary objective of the study is to evaluate the safety and tolerability of single- and
multiple-ascending oral doses of BIIB095 in healthy participants. The secondary objectives
are to characterize the single- and multiple-oral-dose PK of BIIB095 in healthy participants
and to investigate the effect of food on the single-oral-dose PK of BIIB095 in healthy
participants.
创建时间：
2025-07-07
